A Novel Mitochondria-Targeting Iron Chelator Neuroprotects Multimodally via HIF-1 Modulation Against a Mitochondrial Toxin in a Dopaminergic Cell Model of Parkinson’s Disease

[1]  C. Pourzand,et al.  The synthesis and properties of mitochondrial targeted iron chelators , 2022, BioMetals.

[2]  S. Rutella,et al.  Hypoxia Signaling in Parkinson’s Disease: There Is Use in Asking “What HIF?” , 2021, Biology.

[3]  C. Ríos,et al.  Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP+ Model of Parkinson’s Disease , 2021, Neurochemical Research.

[4]  D. Song,et al.  Dexmedetomidine protects SH‐SY5Y cells against MPP+‐induced declining of mitochondrial membrane potential and cell cycle deficits , 2021, The European journal of neuroscience.

[5]  I. Yanatori,et al.  Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies , 2021, Redox biology.

[6]  Linxi Chen,et al.  Mitochondrial iron metabolism and its role in diseases. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[7]  I. Yanatori,et al.  Iron loss triggers mitophagy through induction of mitochondrial ferritin , 2020, EMBO reports.

[8]  Dongfeng Chen,et al.  FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson’s Disease , 2020, Neurotherapeutics.

[9]  J. Elson,et al.  Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants , 2020, Archives of Toxicology.

[10]  A. Poetsch.  The genomics of oxidative DNA damage, repair, and resulting mutagenesis , 2020, Computational and structural biotechnology journal.

[11]  F. Salachas,et al.  Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis , 2020, Journal of Neural Transmission.

[12]  J. Trojanowski,et al.  α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies , 2019, Neuroscience Letters.

[13]  Dongfeng Chen,et al.  Moxibustion Exerts a Neuroprotective Effect through Antiferroptosis in Parkinson's Disease , 2019, Evidence-based complementary and alternative medicine : eCAM.

[14]  D. Stanković,et al.  Use of cyclic voltammetry to determine the antioxidant capacity of berry fruits: correlation with spectrophotometric assays , 2019, European Journal of Horticultural Science.

[15]  Guozhen Fang,et al.  Intracellular Fenton reaction based on mitochondria-targeted copper(ii)–peptide complex for induced apoptosis , 2019, Journal of Materials Chemistry B.

[16]  R. Anjum,et al.  Parkinson's disease: Mechanisms, translational models and management strategies , 2019, Life sciences.

[17]  D. Turnbull,et al.  Mitochondrial Dysfunction in Parkinson’s Disease—Cause or Consequence? , 2019, Biology.

[18]  D. Long,et al.  HIF-1α protects against oxidative stress by directly targeting mitochondria , 2019, Redox biology.

[19]  C. Lim,et al.  A 3D microvascular network model to study the impact of hypoxia on the extravasation potential of breast cell lines , 2018, Scientific Reports.

[20]  M. Tambuwala,et al.  Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitis , 2018, Drug Delivery and Translational Research.

[21]  Marcus Groettrup,et al.  Prevention of neuronal apoptosis by astrocytes through thiol-mediated stress response modulation and accelerated recovery from proteotoxic stress , 2018, Cell Death & Differentiation.

[22]  M. Núñez,et al.  New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases , 2018, Pharmaceuticals.

[23]  K. Wimalasena,et al.  Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4'I-MPP+ , 2018, bioRxiv.

[24]  M. Núñez,et al.  Development of an iron-selective antioxidant probe with protective effects on neuronal function , 2017, PloS one.

[25]  E. Isachenko,et al.  Use of the fluorescent dye tetramethylrhodamine methyl ester perchlorate for mitochondrial membrane potential assessment in human spermatozoa , 2017, Andrologia.

[26]  S. Sollott,et al.  Mitochondrial membrane potential. , 2017, Analytical biochemistry.

[27]  Anthony R. White,et al.  Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease , 2017, Neurochemistry International.

[28]  YongKeun Park,et al.  Measurements of morphological and biophysical alterations in individual neuron cells associated with early neurotoxic effects in Parkinson's disease , 2017, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[29]  F. Heredia,et al.  Cyclic voltammetry to evaluate the antioxidant potential in winemaking by-products. , 2017, Talanta.

[30]  F. Torti,et al.  Mitochondria and Iron: current questions , 2017, Expert review of hematology.

[31]  Simon C Watkins,et al.  Live imaging of mitochondrial dynamics in CNS dopaminergic neurons in vivo demonstrates early reversal of mitochondrial transport following MPP+ exposure , 2016, Neurobiology of Disease.

[32]  C. Pourzand,et al.  A Powerful Mitochondria-Targeted Iron Chelator Affords High Photoprotection against Solar Ultraviolet A Radiation , 2016, The Journal of investigative dermatology.

[33]  W. Vilegas,et al.  LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds , 2016, Cytotechnology.

[34]  S. Kuo,et al.  The epigenetic regulation of HIF-1α by SIRT1 in MPP(+) treated SH-SY5Y cells. , 2016, Biochemical and biophysical research communications.

[35]  Kawinthra Khwanraj,et al.  Differential Expression of Tyrosine Hydroxylase Protein and Apoptosis-Related Genes in Differentiated and Undifferentiated SH-SY5Y Neuroblastoma Cells Treated with MPP+ , 2015, Neurology research international.

[36]  M. Núñez,et al.  The novel mitochondrial iron chelator 5-((methylamino)methyl)-8-hydroxyquinoline protects against mitochondrial-induced oxidative damage and neuronal death. , 2015, Biochemical and biophysical research communications.

[37]  Marta A. Uzarska,et al.  Compartmentalization of iron between mitochondria and the cytosol and its regulation. , 2015, European journal of cell biology.

[38]  R. Lill,et al.  The role of mitochondria and the CIA machinery in the maturation of cytosolic and nuclear iron-sulfur proteins. , 2015, European journal of cell biology.

[39]  M. Núñez,et al.  Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders. , 2015, Mitochondrion.

[40]  R. Lill,et al.  The role of mitochondria in cytosolic-nuclear iron–sulfur protein biogenesis and in cellular iron regulation. , 2014, Current opinion in microbiology.

[41]  Pamela J. Shaw,et al.  Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis , 2014, Neurobiology of Aging.

[42]  B. Głód,et al.  Total antioxidant potential assay with cyclic voltammetry and/or differential pulse voltammetry measurements , 2014 .

[43]  C. Mawrin,et al.  Review: Iron metabolism and the role of iron in neurodegenerative disorders , 2014, Neuropathology and applied neurobiology.

[44]  R. Rego,et al.  Comparative study of the antioxidant capacity and polyphenol content of Douro wines by chemical and electrochemical methods. , 2013, Food chemistry.

[45]  M. Grabolle,et al.  Relative and absolute determination of fluorescence quantum yields of transparent samples , 2013, Nature Protocols.

[46]  R. Lill,et al.  The role of mitochondria in cellular iron-sulfur protein biogenesis: mechanisms, connected processes, and diseases. , 2013, Cold Spring Harbor perspectives in biology.

[47]  Marta A. Uzarska,et al.  The role of mitochondria in cellular iron-sulfur protein biogenesis and iron metabolism. , 2012, Biochimica et biophysica acta.

[48]  T. Schwarz,et al.  The pathways of mitophagy for quality control and clearance of mitochondria , 2012, Cell Death and Differentiation.

[49]  B. Van Houten,et al.  Impaired mitochondrial biogenesis contributes to depletion of functional mitochondria in chronic MPP+ toxicity: dual roles for ERK1/2 , 2012, Cell Death and Disease.

[50]  T. Rouault.  Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease , 2012, Disease Models & Mechanisms.

[51]  M. Ashcroft,et al.  HIF-1α localization with mitochondria , 2011, Cell cycle.

[52]  M. Das,et al.  Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade , 2011, Journal of Neuroinflammation.

[53]  G. Semenza.  Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. , 2011, Biochimica et biophysica acta.

[54]  D. Hauchard,et al.  Total phenolic contents, radical scavenging and cyclic voltammetry of seaweeds from Brittany , 2011 .

[55]  K. O’Malley,et al.  The Parkinsonian Mimetic, MPP+, Specifically Impairs Mitochondrial Transport in Dopamine Axons , 2011, The Journal of Neuroscience.

[56]  M. Núñez,et al.  Iron mediates neuritic tree collapse in mesencephalic neurons treated with 1-methyl-4-phenylpyridinium (MPP+) , 2011, Journal of Neural Transmission.

[57]  S. Perry,et al.  Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. , 2011, BioTechniques.

[58]  K. Chan,et al.  Mitochondrial UCP5 is neuroprotective by preserving mitochondrial membrane potential, ATP levels, and reducing oxidative stress in MPP+ and dopamine toxicity. , 2010, Free radical biology & medicine.

[59]  J. Andersen,et al.  Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease , 2009, Brain Research.

[60]  E. Gnaiger.  Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. , 2009, The international journal of biochemistry & cell biology.

[61]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[62]  S. Vatner,et al.  Downregulation of MiR-199a Derepresses Hypoxia-Inducible Factor-1α and Sirtuin 1 and Recapitulates Hypoxia Preconditioning in Cardiac Myocytes , 2009, Circulation research.

[63]  E. Gnaiger.  Polarographic Oxygen Sensors, the Oxygraph, and High‐Resolution Respirometry to Assess Mitochondrial Function , 2008 .

[64]  M. Rathbone,et al.  MPP+-induced cytotoxicity in neuroblastoma cells: Antagonism and reversal by guanosine , 2007, Purinergic Signalling.

[65]  M. Elstner,et al.  Individual dopaminergic neurons show raised iron levels in Parkinson disease , 2007, Neurology.

[66]  Maya Shvartsman,et al.  Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells. , 2005, Blood.

[67]  F. Sun,et al.  Melatonin protects against MPTP/MPP+‐induced mitochondrial DNA oxidative damage in vivo and in vitro , 2005, Journal of pineal research.

[68]  D. Richardson,et al.  Iron trafficking in the mitochondrion: novel pathways revealed by disease. , 2005, Blood.

[69]  A. M. Brett,et al.  Electrochemical Oxidation of Quercetin , 2003 .

[70]  F. Petrat,et al.  Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor. , 2002, The Biochemical journal.

[71]  I. Wilson,et al.  Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. , 2000, European journal of biochemistry.

[72]  A. Graybiel,et al.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.

[73]  J C Reed,et al.  Mitochondria and apoptosis. , 1998, Science.

[74]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[75]  L. Bruce,et al.  Electron microscopic differentiation of directly and transneuronally transported DiI and applications for studies of synaptogenesis , 1997, Journal of Neuroscience Methods.

[76]  M. G. Honig,et al.  Dil and DiO: versatile fluorescent dyes for neuronal labelling and pathway tracing , 1989, Trends in Neurosciences.

[77]  C. Marsden,et al.  Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.

[78]  C. Marsden,et al.  INCREASED NIGRAL IRON CONTENT IN POSTMORTEM PARKINSONIAN BRAIN , 1987, The Lancet.

[79]  W. Nicklas,et al.  Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.

[80]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[81]  F. Fornai,et al.  MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson’s Disease , 2021, Handbook of Neurotoxicity.

[82]  M. Teitell,et al.  Techniques to monitor glycolysis. , 2014, Methods in Enzymology.

[83]  D. Lee,et al.  Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[84]  U. Walter.  Transcranial sonography in brain disorders with trace metal accumulation. , 2010, International review of neurobiology.

[85]  Dean P. Jones,et al.  Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[86]  Simon C Watkins,et al.  Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. , 2007, The American journal of pathology.

[87]  C. Gabriel,et al.  Effect of 1-methyl-4-phenylpyridinium (MPP+) on mitochondrial membrane potential in cerebellar neurons: Interaction with the NMDA receptor , 2005, Journal of Neural Transmission.

[88]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[89]  K. Suzuki,et al.  Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration. , 1990, Advances in neurology.